Results of the integrated ABC/VEN/frequency analysis of the s01e “antiglaucoma drugs and miotics” group medicines use by indicators of expenses, vital necessity and frequency of use

Authors

  • Ольга Володимирівна Макаренко State Establishment "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" Dzerzhinsky str., 9, Dnipro, Ukraine, 49044
  • Олена Вікторівна Кривов'яз I. M. Pyrohov Vinnytsia National Medical University Pyrohov str., 56, Vinnytsia, Ukraine, 21018 http://orcid.org/0000-0001-5441-1903

DOI:

https://doi.org/10.15587/2519-4852.2016.85906

Keywords:

pharmacoeconomic analysis, ABC/VEN/frequency analysis, antiglaucoma drugs, expensiveness, vital necessity, prescription frequency

Abstract

Pharmacotherapy efficiency for ophthalmology patients with primary open angle glaucoma depends both on pathological process features and physician’s qualification, and on the ability of funds rising to purchase antiglaucoma drugs, as well. One of the pharmaceutical provision optimization mechanisms for the given group of patients is the implementation of the formulary system and mandatory health insurance.

Aim. To substantiate the economic feasibility of including antiglaucoma drugs into the formulary and insurance lists using complex ABC/VEN/frequency analysis.

Materials and methods. The analysis of 758 prescriptions of antiglaucoma drugs for patients having primary open angle glaucoma, which were on the dispensary in hospitals of Vinnitsa region, was carried out.

Results. The ABC-analysis showed that 21% of drugs are the most expendable, while 55% of drugs of the studied group accounted for only 5% of the cost. The VEN-analysis results show that the group of the essential AGD is the most numerous – 82.25%. The complex ABC/VEN analysis allowed determination of the essential and necessary AGD with the highest and mean indexes of POAG pharmacotherapy, which share is 34.48%. During frequency analysis it was determined that 82.76% of POAG treatment schemes contained the essential drugs. Expert estimation data of the expediency of AGD implementation into the formulary and insurance lists, which partially did not corresponded the State formulary content, indicate the necessity to attract more professionals of the certain heath care sector for development of the lists mentioned above.

Conclusion. The data, obtained in result of the ABC/VEN/frequency analysis of AGD use, show the necessity of pharmacotherapy optimization for patients having POAG, based on the results of complex pharmacoeconomic studies, under conditions of reforming health care system concerning the insurance medicine implementation in Ukraine

Author Biographies

Ольга Володимирівна Макаренко, State Establishment "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" Dzerzhinsky str., 9, Dnipro, Ukraine, 49044

Doctor of Medicine, professor

Department of social medicine, organization and health management

Олена Вікторівна Кривов'яз, I. M. Pyrohov Vinnytsia National Medical University Pyrohov str., 56, Vinnytsia, Ukraine, 21018

PhD, Associate Professor, Head of Department

Department of Pharmacy 

 

References

Primary open-angle glaucoma. Adapted clinical guidelines based on evidence (2011). Available at: http://www.dec.gov.ua/mtd/dodatki/816/816dod4_2.doc

Damji, K. F., Freedman, S., Moroi, S. E., Douglas, J. R., Shields, M. B. (2010). Shields’ Textbook of Glaucoma. Lippincott Williams & Wilkins, 656.

Kryvoviaz, O. V. (2013). Farmakoterapiia hlaukomy: suchasnyi stan problemy [Pharmacotherapy of glaucoma: state of the problem]. Farmakolohiia ta likarska toksykolohiia, 4–5 (35), 3–13.

Makarenko, O. V., Kryvoviaz, O. V., Kryvoviaz, S. O. (2014). Porivniannia kursovykh doz protyhlaukomnykh preparativ u DDD /na rik/ na 1 khvoroho ta yikh vartosti dlia vyboru efektyvnoho ta ekonomichno dostupnoho likuvannia [Comparison doses term antiglaucoma drugs in DDD / year / in 1 patient and their value to select effective and affordable treatment]. Klinichna farmatsiia, 18 (3), 25–30.

Kryvoviaz, O. (2016). Antiglaucoma pharmacotherapy: analysis of treatment regimens and efficacy indicators. ScienceRise, 3/4 (20), 46–50. doi: 10.15587/2313-8416.2016.65160

Makarenko, O. V., Kryvoviaz, O. V. (2014). Otsenka kachestva zhizni bolnykh pervichnoy otkrytougolnoy glaukomoy [Quality of life of patients with primary open angle glaucoma]. Materialy nauchnoy konferentsii «Sovremennaya farmatsevtika: teoriya, praktika, eksperimenty», 48–53.

Blihar, V. E. et. al. (2011). Do pitannya vprovadzhennya formulyarnoyi sistemi v Ukrayini [On the issue of implementation of formulary system in Ukraine]. Shidnoevropeyskiy zhurnal gromadskogo zdorov’ya, 1 (13), 70–71.

Stepanenko, A. V., Blikhar, V. Ye. (2014). Intehratsiia formuliarnoi systemy likarskykh zasobiv u systemu standartiv u sferi okhorony zdorovia [Integration of drugs formulary system to the system of standards in health care]. Visnyk problem biolohii i medytsyny, 3 (1), 330–333.

Vorobev, P. A. (2008). Kliniko-ekonomicheskiy analiz v meditsinskoy organizatsii [Clinical and economic analysis in the medical organization]. Ratsionalnaya farmakoterapiya, 1 (10), 5–14.

Pro zatverdzhennja chetvertogo vipusku Derzhavnogo formuljara lіkars'kih zasobіv ta zabezpechennja jogo dostupnostі (2012). Mіnіsterstvo ohoroni zdorov'ja Ukraїni, 209. Available at: http://moz.gov.ua/ua/portal/dn_20120328_209.html

Published

2016-12-28

How to Cite

Макаренко, О. В., & Кривов’яз, О. В. (2016). Results of the integrated ABC/VEN/frequency analysis of the s01e “antiglaucoma drugs and miotics” group medicines use by indicators of expenses, vital necessity and frequency of use. ScienceRise: Pharmaceutical Science, (4 (4), 9–13. https://doi.org/10.15587/2519-4852.2016.85906

Issue

Section

Pharmaceutical Science